Masaru Matsuda
General Counsel, Halozyme Therapeutics.
Companies
- Arcutis Biotherapeutics, Inc.See Remark Nov 22, 2022 to now1
- Arcutis Biotherapeutics, Inc.General counsel Jan 5, 2022 to Jun 2, 20222
- Halozyme TherapeuticsGeneral counsel Jan 6, 2020 to Sep 7, 20213
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Arcutis Biotherapeutics, Inc. ARQT112,508 shares4$3.7M at $32.50Sep 16, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Sep 16, 2026Sold 3,674 shares at $25.00 of Arcutis Biotherapeutics, Inc.4
- Sep 8, 2026Sold 9,989 shares at $25.03 of Arcutis Biotherapeutics, Inc.5
- Aug 3, 2026Sold 1,230 shares at $26.12 of Arcutis Biotherapeutics, Inc.6
- May 4, 2026Sold 884 shares at $23.61 of Arcutis Biotherapeutics, Inc.7
- May 4, 2026Sold 7,372 shares at $23.27 of Arcutis Biotherapeutics, Inc.7
- Mar 2, 2026Sold 1,987 shares at $25.70 of Arcutis Biotherapeutics, Inc.8
- Mar 2, 2026Sold 193 shares at $25.91 of Arcutis Biotherapeutics, Inc.8
- Mar 2, 2026Sold 6,553 shares at $25.16 of Arcutis Biotherapeutics, Inc.8
- Feb 27, 2026Sold 3,325 shares at $27.95 of Arcutis Biotherapeutics, Inc.8
- Feb 27, 2026Granted 37,000 shares of Arcutis Biotherapeutics, Inc.8
- Feb 2, 2026Sold 4,714 shares at $25.63 of Arcutis Biotherapeutics, Inc.9
- Feb 2, 2026Sold 19,379 shares at $25.24 of Arcutis Biotherapeutics, Inc.9
- Feb 2, 2026Sold 8,562 shares at $24.97 of Arcutis Biotherapeutics, Inc.9
- Feb 2, 2026Sold 7,983 shares at $25.50 of Arcutis Biotherapeutics, Inc.9
- Dec 1, 2025Sold 1,657 shares at $30.23 of Arcutis Biotherapeutics, Inc.10
- Nov 19, 2025Sold 1,561 shares at $28.50 of Arcutis Biotherapeutics, Inc.11
- Nov 19, 2025Sold 989 shares at $27.95 of Arcutis Biotherapeutics, Inc.11
- Nov 3, 2025Sold 43 shares at $25.40 of Arcutis Biotherapeutics, Inc.12
- Nov 3, 2025Sold 7,165 shares at $24.71 of Arcutis Biotherapeutics, Inc.12
- Sep 4, 2025Sold 36,130 shares at $16.16 of Arcutis Biotherapeutics, Inc.13
- Aug 4, 2025Sold 6,330 shares at $14.33 of Arcutis Biotherapeutics, Inc.14
- May 28, 2025Sold 1,800 shares at $13.78 of Arcutis Biotherapeutics, Inc.15
- May 2, 2025Sold 5,030 shares at $15.20 of Arcutis Biotherapeutics, Inc.16
- Mar 3, 2025Sold 3,263 shares at $13.03 of Arcutis Biotherapeutics, Inc.17
- Feb 28, 2025Granted 34,000 shares of Arcutis Biotherapeutics, Inc.17
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5SEC EDGARForm 4 filed Sep 10, 2026
- 6SEC EDGARForm 4 filed Aug 5, 2026
- 7SEC EDGARForm 4 filed May 6, 2026
- 8SEC EDGARForm 4 filed Mar 3, 2026
- 9SEC EDGARForm 4 filed Feb 4, 2026
- 10SEC EDGARForm 4 filed Dec 3, 2025
- 11SEC EDGARForm 4 filed Nov 21, 2025
- 12SEC EDGARForm 4 filed Nov 5, 2025
- 13SEC EDGARForm 4 filed Sep 8, 2025
- 14SEC EDGARForm 4 filed Aug 5, 2025
- 15SEC EDGARForm 4 filed May 29, 2025
- 16SEC EDGARForm 4 filed May 5, 2025
- 17SEC EDGARForm 4 filed Mar 4, 2025